Company Overview
Royal Philips N.V. is a global health technology company focused on diagnostic imaging, image-guided therapy, monitoring, enterprise informatics and personal health. In ATP terms, Philips is relevant because advanced processors, sensing technologies, embedded electronics and AI-enabled computing become strategically meaningful when they are integrated into medical systems that support diagnosis, treatment and connected care. [1] [2]
What Philips does
Philips designs and sells complex healthcare systems including MRI, CT, ultrasound, image-guided therapy platforms, patient monitoring equipment, connected care software and selected consumer health products. For ATP, the company matters not as a semiconductor producer, but as a major downstream systems integrator that embeds advanced compute, imaging electronics, sensors, software and AI into high-value, safety-critical healthcare applications. [1] [3]
ATP relevance
Philips sits in the application and systems layer of ATP. Its strategic relevance comes from converting advances in processors, imaging electronics, sensing, connectivity and AI into deployable medical infrastructure, where reliability, regulatory compliance and clinical performance matter as much as raw chip capability. [1] [4]
Verified key facts
- Philips reported EUR 18.0 billion in sales in 2025. [1]
- Segment sales in 2025 were EUR 8,825 million for Diagnosis & Treatment, EUR 5,138 million for Connected Care, and EUR 3,602 million for Personal Health. [2]
- Philips invested more than EUR 1.7 billion annually in R&D, around 9% of sales. [5]
- In 2024 Philips was the leading applicant in medical technology at the EPO with 594 Medtech patent applications. [6]
- In 2025 Philips ranked No. 1 among medtech companies in the EPO dashboard and filed 676 Medtech patent applications. [7]
Company Logo
Update image path
Royal Philips N.V.
ATP focus: medical imaging, connected care, embedded compute, healthcare AI and regulated systems integration [4]
Philips’ mission is to improve people’s health and well-being through meaningful innovation. In ATP terms, that mission is implemented through complex electronic and software-defined medical systems that depend on advanced chips, high-performance sensing, secure connectivity and AI-enabled analysis. [1] [4]
Strategic vision
- Diagnosis & Treatment: imaging and interventional systems for hospitals and clinicians. [2]
- Connected Care: monitoring, enterprise informatics, digital platforms and operational intelligence. [2] [4]
- Personal Health: consumer-oriented health and wellness devices. [2]
For ATP, Philips is a downstream systems company that monetizes semiconductor-enabled functionality through regulated healthcare products, software and services rather than through chip sales themselves. [1]
Diagnostic and treatment systems
- MRI, CT, ultrasound and image-guided therapy systems rely on sophisticated embedded electronics, sensing and compute-intensive image processing. [3]
Connected care and software
- Philips positions data and AI as a structural advantage for translating system integration into actionable clinical and operational intelligence. [4]
Personal health
- Consumer devices extend the company’s ATP relevance into edge health and wellness applications. [2]
| Metric | Value |
|---|---|
| 2025 sales | EUR 18.0 billion [1] |
| Diagnosis & Treatment sales 2025 | EUR 8,825 million [2] |
| Connected Care sales 2025 | EUR 5,138 million [2] |
| Personal Health sales 2025 | EUR 3,602 million [2] |
| R&D intensity | > EUR 1.7 billion, around 9% of sales [5] |
| Innovation position | No. 1 medtech company at EPO [7] |
ATP from Philips’ perspective
From Philips’ perspective, ATP is not mainly about who fabricates the chip. It is about whether advanced compute, sensors, imaging electronics, software and AI can be integrated into trusted, regulated and clinically effective systems that improve diagnosis, treatment and care delivery. [1] [4]
Availability
- Availability means reliable access to advanced electronics, imaging subsystems and digital platforms for healthcare deployment at scale. [3]
- This includes the practical ability of hospitals and care systems to deploy technology-rich equipment and connected care infrastructure. [4]
Technology
- The technology dimension centers on imaging performance, embedded processing, clinical software, AI-enabled workflows and system interoperability. [3] [4]
- That makes Philips a strong example of how ATP value is created in regulated application domains beyond the semiconductor fab itself. [5]
Policy and resilience
- Philips is strategically relevant because healthcare sovereignty depends on robust access to advanced medical technology systems, not just access to chips in isolation. [1]
- Its role shows that resilient ATP ecosystems require downstream European leaders able to transform semiconductor capability into medical infrastructure with strong IP, service and regulatory capabilities. [7]